CoChat

A Small Molecule That Binds and Inhibits the ETV1 Transcription Factor Oncoprotein

Open access
Pop, Marius S., Stransky, Nicolas, Garvie, Colin W., Theurillat, Jean-Philippe, Hartman, Emily C., Lewis, Timothy A., Zhong, Cheng, Culyba, Elizabeth K., Lin, Fallon, Daniels, Douglas S., Pagliarini, Raymond, Ronco, Lucienne, Koehler, Angela N., Garraway, Levi A. · 2014 · Molecular Cancer Therapeutics
Cited by 65

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Members of the ETS transcription factor family have been implicated in several cancers, where they are often dysregulated by genomic derangement. ETS variant 1 (ETV1) is an ETS factor gene that undergoes chromosomal translocation in prostate cancers and Ewing sarcomas, amplification in melanomas, and lineage dysregulation in gastrointestinal stromal tumors. Pharmacologic perturbation of ETV1 would be appealing in these cancers; however, oncogenic transcription factors are often deemed “undruggable” by conventional methods. Here, we used small-molecule microarray screens to identify and characterize drug-like compounds that modulate the biologic function of ETV1. We identified the 1,3,5-triazine small molecule BRD32048 as a top candidate ETV1 perturbagen. BRD32048 binds ETV1 directly, modulating both ETV1-mediated transcriptional activity and invasion of ETV1-driven cancer cells. Moreover, BRD32048 inhibits p300-dependent acetylation of ETV1, thereby promoting its degradation. These results point to a new avenue for pharmacologic ETV1 inhibition and may inform a general means to discover small molecule perturbagens of transcription factor oncoproteins. Mol Cancer Ther; 13(6); 1492–502. ©2014 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1535-7163.mct-13-0689

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 65

Metadata

Authors
Pop, M. S., Stransky, N., Garvie, C. W., Theurillat, J.-P., Hartman, E. C., Lewis, T. A., Zhong, C., Culyba, E. K., Lin, F., Daniels, D. S., Pagliarini, R., Ronco, L., Koehler, A. N., & Garraway, L. A.
Venue
Molecular Cancer Therapeutics
Published
2014-06-01
Volume
13
Issue
6
Pages
1492-1502
ISSN
  • 1535-7163 (ISSN-L)
  • 1538-8514
OpenAlex
W2213200173
Cited by
65
References
9
FWCI
2.19
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Small Molecule That Binds and Inhibits the ETV1 Transcription Factor Oncoprotein. https://app.cochat.ai/papers/10.1158/1535-7163.mct-13-0689
The paper
Pop, M. S., Stransky, N., Garvie, C. W., Theurillat, J.-P., Hartman, E. C., Lewis, T. A., Zhong, C., Culyba, E. K., Lin, F., Daniels, D. S., Pagliarini, R., Ronco, L., Koehler, A. N., & Garraway, L. A. (2014). A Small Molecule That Binds and Inhibits the ETV1 Transcription Factor Oncoprotein. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-13-0689

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.